Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_assertion type Assertion NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_head.
- NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_assertion description "[Allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for chronic myeloid leukemia and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia, and the graft-vs-leukemia (GVL) effect can eradicate residual leukemia after allo-SCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_provenance.
- NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_assertion evidence source_evidence_literature NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_provenance.
- NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_assertion SIO_000772 22665066 NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_provenance.
- NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_assertion wasDerivedFrom befree-20140225 NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_provenance.
- NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_assertion wasGeneratedBy ECO_0000203 NP612253.RAN0pOEj8kaCFJwu94k6YqgM7UgmCKjNQuliUqIAIv6IU130_provenance.